1. Allergic asthma: an overview of metabolomic strategies leading to the identification of biomarkers in the field. Issue 4 (April 2017) Authors: Villaseñor, A.; Rosace, D.; Obeso, D.; Pérez‐Gordo, M.; Chivato, T.; Barbas, C.; Barber, D.; Escribese, M. M. Journal: Clinical & experimental allergy Issue: Volume 47:Issue 4(2017) Page Start: 442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Answer to: "Biomarkers in allergic asthma: Which matrix should we use?". Issue 8 (12th July 2017) Authors: Villaseñor, A.; Rosace, D.; Obeso, D.; Pérez‐Gordo, M.; Chivato, T.; Barbas, C.; Barber, D.; Escribese, M. M. Journal: Clinical & experimental allergy Issue: Volume 47:Issue 8(2017) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1249: INHIBITION OF THE PENTOSE-PHOSPHATE-PATHWAY (PPP) MEDIATES MACROPHAGE REPROGRAMMING FROM SUPPORTIVE BYSTANDER FUNCTION TOWARDS ANTIBODY-DEPENDENT LYMPHOMA CELL CLEARANCE AND LYMPHOMA SUPPRESSION. (23rd June 2022) Authors: Beielstein, A.; Izquierdo-Alvarez, E.; Nickel, N.; Blakemore, S.; Vorholt, D.; Chawan, S.; Bartel, H.-H.; Wiederstein, J.; Linke, R.; Brinker, R.; Michalik, M.; Costa Picossi, C. R.; Villasenor, A.; Barbas, C.; Krüger, M.; Hallek, M.; Pallasch, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗